The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Isabella Pacchiarotti(Universidade Federal do Rio Grande do Sul), Shigenobu Kanba(Kyushu University), Konstantinos Ν. Fountoulakis(Society for Neuroscience), Beny Lafer(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Boris Birmaher(University of Pittsburgh), Gin S. Malhi(Royal North Shore Hospital), David J. Bond(University of Minnesota), Joseph F. Goldberg(Icahn School of Medicine at Mount Sinai), Mark A. Frye(Mayo Clinic), Ross J. Baldessarini(McLean Hospital), Eric A. Youngstrom(University of North Carolina at Chapel Hill), Athanasios Koukopoulos(Universidade Federal do Rio Grande do Sul), Anabel Martínez‐Arán(Hospital Clínic de Barcelona), Lakshmi N. Yatham(University of British Columbia), Guy M. Goodwin(Warneford Hospital), Joseph R. Calabrese(Case Western Reserve University), Andrew A. Nierenberg(Andrews University), Michael Bauer(University Hospital Carl Gustav Carus), Robert L. Findling(Virginia Commonwealth University), Ana González‐Pinto(Universidade Federal do Rio Grande do Sul), Gustavo Vázquez(Queen's University), Terence A. Ketter(Stanford University), Juan Undurraga(Universidade Federal do Rio Grande do Sul), Gordon Parker(UNSW Sydney), Robert M. Post(George Washington University), Daniel Souery(Universidade Federal do Rio Grande do Sul), Lorenzo Mazzarini(Universidade Federal do Rio Grande do Sul), Paolo Girardi(Ca' Foscari University of Venice), Roy H. Perlis(Massachusetts General Hospital), Marc Valentí(Universidade Federal do Rio Grande do Sul), Francesc Colom(Hospital Del Mar), Heinz Grunze(Paracelsus Medical University), Ayşegül Özerdem(Universidade Federal do Rio Grande do Sul), Leonardo Tondo(Harvard University), Michael Berk(The Royal Melbourne Hospital), Susan L. McElroy(Southwestern Medical Center), Ayşegül Yıldız(Universidade Federal do Rio Grande do Sul), Rasmus Wentzer Licht(Aalborg University Hospital), Carlos A. Zarate(National Institute of Mental Health), Frederick Cassidy(Universidade Federal do Rio Grande do Sul), Willem A. Nolen(Unknown), Hagop S. Akiskal(University of California San Diego), Tadafumi Kato(Juntendo University), Philip B. Mitchell(UNSW Sydney), Michael E. Thase(Unknown), Lori L. Altshuler(Universidade Federal do Rio Grande do Sul), Diego Hidalgo‐Mazzei(Institut d'Investigacions Biomèdiques de Barcelona), Jean-Michel Azorin(Universidade Federal do Rio Grande do Sul), Mauricio Tohen(University of New Mexico)
Cited by 754
Related Papers
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
|Archives of General Psychiatry|2002|2.1k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k